-+ 0.00%
-+ 0.00%
-+ 0.00%

*Novo Nordisk: Hims & Hers Unlawfully Mass Markets Unapproved Versions of Its FDA-approved Semaglutide Medicines >NOVO

Dow Jones·02/09/2026 12:01:00

Please log in to view news